These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19724924)

  • 1. Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas.
    Hutzen B; Friedman L; Sobo M; Lin L; Cen L; De Angelis S; Yamakoshi H; Shibata H; Iwabuchi Y; Lin J
    Int J Oncol; 2009 Oct; 35(4):867-72. PubMed ID: 19724924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030.
    Lin L; Liu Y; Li H; Li PK; Fuchs J; Shibata H; Iwabuchi Y; Lin J
    Br J Cancer; 2011 Jul; 105(2):212-20. PubMed ID: 21694723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.
    Sato A; Kudo C; Yamakoshi H; Uehara Y; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
    Cancer Sci; 2011 May; 102(5):1045-51. PubMed ID: 21272158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells.
    Friedman L; Lin L; Ball S; Bekaii-Saab T; Fuchs J; Li PK; Li C; Lin J
    Anticancer Drugs; 2009 Jul; 20(6):444-9. PubMed ID: 19384191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition.
    Wang X; Zhang Y; Zhang X; Tian W; Feng W; Chen T
    Int J Oncol; 2012 Apr; 40(4):1189-95. PubMed ID: 22179587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells.
    Lin L; Hutzen B; Ball S; Foust E; Sobo M; Deangelis S; Pandit B; Friedman L; Li C; Li PK; Fuchs J; Lin J
    Cancer Sci; 2009 Sep; 100(9):1719-27. PubMed ID: 19558577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma.
    Kudo C; Yamakoshi H; Sato A; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
    Anticancer Res; 2011 Nov; 31(11):3719-26. PubMed ID: 22110192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
    Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
    Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells.
    MaruYama T; Kobayashi S; Nakatsukasa H; Moritoki Y; Taguchi D; Sunagawa Y; Morimoto T; Asao A; Jin W; Owada Y; Ishii N; Iwabuchi Y; Yoshimura A; Chen W; Shibata H
    Front Immunol; 2021; 12():687669. PubMed ID: 34248973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.
    Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N
    Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: their inhibition by curcumin.
    Seo JH; Jeong KJ; Oh WJ; Sul HJ; Sohn JS; Kim YK; Cho DY; Kang JK; Park CG; Lee HY
    Cancer Lett; 2010 Feb; 288(1):50-6. PubMed ID: 19647363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effect of an analog of curcumin bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in human breast cancer cells.
    Kumaravel M; Sankar P; Rukkumani R
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1900-7. PubMed ID: 23242714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells.
    Cen L; Hutzen B; Ball S; DeAngelis S; Chen CL; Fuchs JR; Li C; Li PK; Lin J
    BMC Cancer; 2009 Mar; 9():99. PubMed ID: 19331692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression.
    Glienke W; Maute L; Wicht J; Bergmann L
    Cancer Invest; 2010 Feb; 28(2):166-71. PubMed ID: 20121547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis.
    Díaz Osterman CJ; Gonda A; Stiff T; Sigaran U; Valenzuela MM; Ferguson Bennit HR; Moyron RB; Khan S; Wall NR
    Pancreas; 2016 Jan; 45(1):101-9. PubMed ID: 26348467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice.
    Shimizu K; Sunagawa Y; Funamoto M; Wakabayashi H; Genpei M; Miyazaki Y; Katanasaka Y; Sari N; Shimizu S; Katayama A; Shibata H; Iwabuchi Y; Kakeya H; Wada H; Hasegawa K; Morimoto T
    Sci Rep; 2020 Apr; 10(1):7172. PubMed ID: 32346115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
    Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
    Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A curcumin analogue GO-Y030 depletes cancer stem cells by inhibiting the interaction between the HSP70/HSP40 complex and its substrates.
    Suzuki M; Yamamoto Y; Nishijima-Matsunobu A; Kawasaki Y; Shibata H; Omori Y
    FEBS Open Bio; 2023 Mar; 13(3):434-446. PubMed ID: 36648092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells.
    Ma J; Fang B; Zeng F; Pang H; Zhang J; Shi Y; Wu X; Cheng L; Ma C; Xia J; Wang Z
    Toxicol Lett; 2014 Nov; 231(1):82-91. PubMed ID: 25256401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells.
    Veeraraghavan J; Natarajan M; Lagisetty P; Awasthi V; Herman TS; Aravindan N
    Pancreas; 2011 Oct; 40(7):1107-19. PubMed ID: 21697760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.